Landings by the multi-gear coastal fleet operating off the Portuguese continental coast include about 300 species, from which only a few are the object of management plans. In this study, daily landings (kg trip-1) are used, along with an effort indicator, vessel length overall (LoA), to obtain landings per unit of effort (LPUE) as a proxy for the species relative abundance, for a total of 48 species. LPUE indices were used as a response variable in linear models where year (2012-2016), season, region (north and south) and NAO index were explanatory variables. Seasonal and regional effects were found to significantly affect species abundance for a total of 41 and 40 species respectively, while year trends were found to be significant for 19 species, and the NAO index for 3 species. LPUE density maps are presented for several selected species and a subsample of trips, where VMS records were available. It is proposed that geographic and seasonal changes in LPUE can be used to understand trends in abundance and obtain information that can be used in support regional management plans.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249400 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0258630 | PLOS |
Nat Med
January 2025
Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
Genetic diagnosis of rare diseases requires accurate identification and interpretation of genomic variants. Clinical and molecular scientists from 37 expert centers across Europe created the Solve-Rare Diseases Consortium (Solve-RD) resource, encompassing clinical, pedigree and genomic rare-disease data (94.5% exomes, 5.
View Article and Find Full Text PDFBMJ Paediatr Open
January 2025
Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria
Introduction: The current study aims to give an overview of transition-to-home services provided by perinatal centres in Austria and Switzerland and to evaluate parental satisfaction with the care provided.
Methods: This cross-sectional multicentred study was conducted by performing two surveys between May 2022 and November 2023: one among all level III perinatal centres in Austria (n=7) and Switzerland (n=9) (institutional survey) and one among parents of very preterm infants treated at one selected perinatal centre in each of the two countries (parental survey). Both questionnaires consisted of matching questions focusing on current transition-to-home services.
N Biotechnol
January 2025
Department of Chemical Engineering, University of Almería, 04120, Almería, Spain; Desalination and Photosynthesis Functional Unit, CIESOL Solar Energy Research Centre, 04120, Almería, Spain. Electronic address:
There are now several companies that are producing microalgae such as Arthrospira platensis, Chlorella vulgaris, and Dunaliella salina, among others. They are cultivated mainly in large-scale raceway and tubular photobioreactors. Microalgae production represents a sustainable alternative to conventional biomass production.
View Article and Find Full Text PDFLancet Diabetes Endocrinol
January 2025
Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Endocrinology, Monash Health, Clayton, VIC, Australia.
Background: Primary aldosteronism can be treated medically but there is no standardised method to evaluate treatment outcomes. We aimed to develop criteria for assessing the outcomes of targeted medical treatment of primary aldosteronism, analyse outcomes across an international cohort, and identify factors associated with a complete treatment response.
Methods: An international panel of 31 primary aldosteronism experts used the Delphi method to reach consensus on the definition of complete, partial, or absent biochemical and clinical outcomes of medical treatment of primary aldosteronism.
Bioorg Chem
January 2025
Department of Medicinal Chemistry, Faculty of Pharmacy, Galala University, New Galala 43713, Egypt.
In this current work, we dedicated efforts to designing and synthesizing new 1,2,3-triazole-analogues (5a-d), (6a-d), and (7a-c) to act as dual VEGFR-2 and telomerase inhibitors with promising apoptotic potential. The synthesized analogues were examined against eleven diverse types of cancer cells and two normal cells to assess their ability to inhibit cell growth (GI%). Obviously, compound 7b showed the best average GI% (75.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!